Shu-Zhen Dai
- Topics
- Endometrial and Cervical Cancer Treatments (4 papers)Neonatal Respiratory Health Research (4 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers)
In The Last Decade
Shu-Zhen Dai
30 papers receiving 432 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 235
- Cancer Research 140
- Immunology 81
- Pulmonary and Respiratory Medicine 77
- Oncology 74
Countries citing papers authored by Shu-Zhen Dai
This map shows the geographic impact of Shu-Zhen Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Zhen Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Zhen Dai more than expected).
Fields of papers citing papers by Shu-Zhen Dai
This network shows the impact of papers produced by Shu-Zhen Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Zhen Dai. The network helps show where Shu-Zhen Dai may publish in the future.
Co-authorship network of co-authors of Shu-Zhen Dai
This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Zhen Dai. A scholar is included among the top collaborators of Shu-Zhen Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Zhen Dai. Shu-Zhen Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 31 | |
| 11 | 23 | |
| 12 | 6 | |
| 13 | 14 | |
| 14 | 11 | |
| 15 | 17 | |
| 16 | 1 | |
| 17 | 20 | |
| 18 | [Target-specific cytotoxic activity of recombinant fusion toxin C-CPE-ETA' against CLDN-3,4-overexpressing ovarian cancer cells]. | 1 |
| 19 | [Association of EGFR expression with angiogenesis and chemoresistance in ovarian carcinoma]. | 7 |
| 20 | [Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer]. | 4 |
About Shu-Zhen Dai
Shu-Zhen Dai is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology, having authored 33 papers that have together received 437 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (4 papers), Neonatal Respiratory Health Research (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Cancer Research (140 citations), Reproductive Medicine (42 citations) and Obstetrics and Gynecology (33 citations). Shu-Zhen Dai has collaborated with scholars based in China and Australia. Frequent co-authors include Guang‐Hong Tan, Teng Lv, Lei Wang, Feng‐Ying Huang, Qin Yao, Yingying Lin, Wu-Ping Zheng, Yankui Wang, Hui Zhang and Xingsheng Yang. Their work appears in journals such as PLoS ONE, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.